Probiotics and Their Conceivable Part within the Avoidance or Treatment of Covid-19: A Systematic Review

Document Type : Review Article

Authors

1 Department of Nutrition Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.

2 Department of Health Information Technology, Varastegan Institute for Medical Sciences, Mashhad, Iran

Abstract

Introduction: Today, the use of probiotics is very popular among the public, which has recently been tested in COVID-19. The aim of this study was to collect all studies related to the immune effects of probiotics and their possible role in the prevention or treatment of COVID-19 achieve a comprehensive result. Method: The article is a systematic review that uses the PRISMA checklist to extract articles. After searching for the keywords probiotics, treatment, prevention, coronavirus, and covid-19 and combining them in databases (Google Scholar, PubMed, and Science Direct) according to the inclusion and exclusion criteria, 18 articles were finally reached. Therefore, the articles of the last 10 years (2012-2012) that have been scientifically published in databases were qualitatively analyzed by reviewing both authors. Results: Through the qualitative analysis of most articles, we can mention that the modulation of the gut or lung microbiome is an adjuvant treatment or prevention of COVID-19, due to the immunomodulating properties of probiotics. As well as, based on the results of these articles, probiotics can be effective in reducing the secondary infection caused by Covid-19, modulating the inflammatory response, and reducing the duration of the disease. In addition, the administration of probiotics can be useful as an alternative to ameliorate COVID-19 disease and increase the effectiveness of the vaccine. Conclusion: Based on the evidence, probiotics boost the immune system and could be useful in the prevention or adjunctive treatment of COVID-19. More randomized trials are required to support these findings.

Keywords

References

  1. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424-32.
  2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020.
  3. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386(9997):995-1007.
  4. Pan L, Mu MI, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, Jin Y. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115.
  5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.
  6. Morais AH, Passos TS, Maciel BL, da Silva-Maia JK. Can probiotics and diet promote beneficial immune modulation and purine control in coronavirus infection?. Nutrients. 2020;12(6):1737.
  7. Cabinian A, Sinsimer D, Tang M, Jang Y, Choi B, Laouar Y, et al. Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens. Gut. 2018;67(5):847-59.
  8. Antunes AE, Vinderola G, Xavier-Santos D, Sivieri K. Potential contribution of beneficial microbes to face the COVID-19 pandemic. Int Food Res J. 2020;136:109577.
  9. Baud D, Dimopoulou Agri V, Gibson GR, Reid G, Giannoni E. Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic. Front Public Health. 2020;8:186.
  10. Singh K, Rao A. Probiotics: A potential immunomodulator in COVID-19 infection management. Nutr Res. 2021;87:1-12.
  11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed). 2009;339:b2535.
  12. Li Q, Cheng F, Xu Q, Su Y, Cai X, Zeng F, et al. The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. Int Immunopharmacol. 2021;95:107531.
  13. Bozkurt HS, Quigley EM. The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. Int J Immunopathol Phar. 2020;34:2058738420961304.
  14. Olaimat AN, Aolymat I, Al-Holy M, Ayyash M, Ghoush MA, Al-Nabulsi AA, et al. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci Food. 2020;4(1):1-7.
  15. Mirzaei R, Attar A, Papizadeh S, Jeda AS, Hosseini-Fard SR, Jamasbi E, et al. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19). Arch Virol. 2021:1-22.
  16. Patra S, Saxena S, Sahu N, Pradhan B, Roychowdhury A. Systematic network and meta-analysis on the antiviral mechanisms of probiotics: a preventive and treatment strategy to mitigate SARS-CoV-2 infection. Probiotics Antimicrob Proteins. 2021:1-19.
  17. Sundararaman A, Ray M, Ravindra P, Halami PM. Role of probiotics to combat viral infections with emphasis on COVID-19. Appl Microbiol Biotechnol. 2020:1-16.
  18. Tang H, Bohannon L, Lew M, Jensen D, Jung S-H, Zhao A, et al. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open. 2021;11(5):e047069.
  19. Mullish BH, Marchesi JR, McDonald JA, Pass DA, Masetti G, Michael DR, et al. Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?. Gut Microbes. 2021;13(1):1-9.
  20. Gohil K, Samson R, Dastager S, Dharne M. Probiotics in the prophylaxis of COVID-19: something is better than nothing. 3 Biotech. 2021;11(1):1-10.
  21. Tiwari SK, Dicks LM, Popov IV, Karaseva A, Ermakov AM, Suvorov A, et al. Probiotics at war against viruses: what is missing from the picture?. Front Microbiol. 2020;11:1877.
  22. Akour A. Probiotics and COVID‐19: is there any link?. Lett Appl Microbiol. 2020;71(3):229-34.
  23. Alansari MM, Sahlah SA, AlHumaid L, Singh AR. Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review. J King Saud Univ Sci. 2020:101286.
  24. Gautier T, Gall D-L, Sweidan A, Tamanai-Shacoori Z, Jolivet-Gougeon A, Loréal O, et al. Next-Generation Probiotics and Their Metabolites in COVID-19. Microorganisms. 2021;9(5):941.
  25. Shinde T, Hansbro PM, Sohal SS, Dingle P, Eri R, Stanley R. Microbiota modulating nutritional approaches to countering the effects of viral respiratory infections including SARS-CoV-2 through promoting metabolic and immune fitness with probiotics and plant bioactives. Microorganisms. 2020;8(6):921.
  26. Rozga M, Cheng FW, Handu D. Effects of probiotics in conditions or infections similar to covid-19 on health outcomes: An evidence analysis center scoping review. J Acad Nutr Diet. 2021;121(9):1841-54.
  27. Li Q, Cheng F, Xu Q, Su Y, Cai X, Zeng F, et al. The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. Int Immunopharmacol. 2021;95:107531.
  28. Bzdok D, Dunbar RIM. The Neurobiology of Social Distance. Trends Cogn Sci. 2020;24(9):717-33.
  29. Angurana SK, Bansal A. Probiotics and Coronavirus disease 2019: think about the link. Br J Nutr. 2020:1.
  30. Ceccarelli G, Scagnolari C, Pugliese F, Mastroianni CM, d'Ettorre G. Probiotics and COVID-19. Lancet Gastroenterol Hepatol. 2020;5(8):721-2.
Journal of Nutrition,Fasting and Health
Volume 10, Issue 4
October 2022
Pages 276-281

Files

History

  • Receive Date: 26 September 2022
  • Revise Date: 28 November 2022
  • Accept Date: 04 December 2022

Share

How to cite

Statistics